Shanghai Wibson Biotechnology: difference between revisions
Diff·revision 46 → 47·00:17, 6 Oct 2025
Difference between revision 46 and revision 47 of Shanghai Wibson Biotechnology. 2 lines changed; the page grew by 207 bytes.
| Revision 46 — 16:49, 28 Sep 2025 DiffWatchDov (talk) rm maintenance tag, addressed 9,642 bytes ±0 | Revision 47 — 00:17, 6 Oct 2025 BlankVialBo (talk) tag [citation needed] 9,849 bytes +207 | ||
|---|---|---|---|
| 68 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} | 68 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} |
| 69 | 69 | ||
| + | 70 | PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.{{r|tally}} | |
| + | 71 | ||
| 70 | == Regulatory position and legal status == | 72 | == Regulatory position and legal status == |
| 71 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} | 73 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} |